Oracle, Amgen Sell $13.5 Billion of Bonds to Boost Shareholders

Updated on

Shareholders of Oracle Corp. and Amgen Inc. are benefiting from the cheap cost to borrow in the bond market.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.